Paul Nelles

Vice President, Vetter Development Service, Vetter Pharma-Fertigung GmbH & Co. KG

Key technical considerations when developing a clinical project in the biotech world.

Biotechnology projects are complex and subject to many levels of risk during the early clinical phases. What are the secrets to winning at the drug development game?